Although PCAT-1 has been shown to stabilize cMyc level in prostate cancer cells, it has been shown to exert such effect post-transcriptionally by abolishing the down-regulation of cMyc by miR-34a        14 . Here, PCAT1 is linked to prostate carcinoma.